Milestone Pharmaceuticals Inc (NASDAQ:MIST)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MIST

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MIST

  • Market Cap$170.750m
  • SymbolNASDAQ:MIST
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA59935V1076

Company Profile

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.

Latest MIST news

Currently there for this company. Visit our news hub for other news .